Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL 137 W DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL 137 W DEXTROSE 4 25 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: DIANEAL 137 W DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL 137 W DEXTROSE 4 25 IN PLASTIC CONTAINER.
DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER vs DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
DIANEAL 137 with 1.5% dextrose is a peritoneal dialysis solution that removes waste products and excess fluid from the blood by creating a concentration gradient across the peritoneal membrane via diffusion and ultrafiltration. Dextrose acts as an osmotic agent to drive fluid removal.
Intraperitoneal administration of Dianeal with 4.25% dextrose creates an osmotic gradient across the peritoneal membrane, promoting ultrafiltration and removal of uremic toxins and excess fluid.
Intraperitoneal administration: 2 liters per exchange, typically 4 exchanges per day for continuous ambulatory peritoneal dialysis (CAPD).
Intraperitoneal administration: 2 liters infused over 10-20 minutes, dwell time 4-6 hours, then drain over 15-20 minutes; 4 exchanges per 24 hours.
None Documented
None Documented
Not applicable for dextrose as it is an endogenous substance. Exogenous dextrose in peritoneal dialysis is rapidly metabolized; plasma glucose half-life is approximately 1-2 hours after absorption, but this varies with metabolic state.
Dextrose: approximately 1.5–2 hours (systemic half-life in renal impairment; peritoneal equilibration half-life for dextrose in dialysate is 1–2 hours, reflecting absorption).
Dianeal 137 with 1.5% dextrose is a peritoneal dialysis solution. Dextrose is metabolized systemically; glucose is absorbed via peritoneal route and undergoes endogenous metabolism. Icodextrin (if applicable) is metabolized to maltose and excreted renally, but for this standard solution, elimination is primarily via metabolism to CO2 and water; less than 5% excreted unchanged in urine. No biliary or fecal elimination of intact dextrose.
Peritoneal dialysis: Dextrose is metabolized systemically and eliminated primarily as CO2. Unchanged dextrose undergoes renal elimination only in anuric patients on dialysis, with minimal biliary/fecal excretion (<2%).
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution